Cimeio Therapeutics

Luminary Therapeutics

This biotechnology company develops cell therapies to treat patients with cancers and autoimmune diseases.

Immitra Bio

This company develops an in-vivo gene editing platform to provide off-the-shelf curative treatments for patients with rare genetic diseases.

Orca Bio

This company develops high-precision allogeneic cell therapies to treat patients with blood cancers and autoimmune diseases by replacing diseased immune systems with donor cells.

Clade Therapeutics

This biotechnology company develops stem cell-derived medicines to treat patients with cancer and autoimmune diseases.

EdiTy Therapeutics

This company develops immune cell delivery platforms to transport therapeutic proteins into diseased cells for patients with cancer and genetic disorders.

Azalea Therapeutics

The company develops in vivo genome editing therapies to engineer T cells directly inside the body for patients with cancer and autoimmune diseases.

Thymmune

This biotechnology company develops scalable thymic cell therapies to restore immune function for patients with immunodeficiencies, autoimmune disorders, and transplant-related conditions.

Ouro Medicines

This biotechnology firm develops T-cell engager therapies to treat patients living with chronic immune-mediated diseases.